Not yet taking people in SpainPhase 4
SGLT2 inhibitors in people with long-lasting atrial fibrillation and heart failure
Tests SGLT2 inhibitors in older adults with permanent atrial fibrillation and heart failure.
Plain-language title generated from the registry record
Registry title: iSGLT2 in permanent atrial fibrillation, heart failure with preserved ejection fraction and intermediate NT-proBNP values: randomized clinical trial
Key facts
- Where
- Badalona, Barcelona, Gijón, Reus, and Sabadell, SpainSee the 5 sites
- Phase
- Phase 4
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 65 and over who have atrial fibrillation and heart failure. It tests iSGLT2 treatment.
- Age
- 65 years and older
- Sex
- Men and women can join.
Read by machine on 9 November 2026.
Where in Spain
- Hospital Germans Trias i PujolBadalona, SpainNot yet recruiting
- Hospital de la Santa Creu i Sant PauBarcelona, SpainNot yet recruiting
- Hospital Universitario de CabueñesGijón, SpainNot yet recruiting
- Salut Sant Joan de ReusReus, SpainNot yet recruiting
- Parc Tauli Hospital UniversitariSabadell, SpainNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut D Investigacio Sanitaria Pere Virgili
- Trial code
- EU 2026-525968-18-00
- Record updated
- 6 November 2026